Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ReIrradiation With FDG-PET Guided Dose Painting for Recurrent and Second Primary Head and Neck Cancer

NCT02921581 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT02921581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02921581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ReIrradiation With FDG-PET Guided Dose Painting for Recurrent and Second Primary Head and Neck Cancer
Lead sponsor
Oslo University Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2015
Completion date
August 31, 2023
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer